Third-generation sequencing
Third-generation Sequencing
Third-generation sequencing (TGS) refers to a class of DNA sequencing technologies that enable the direct sequencing of single DNA molecules without the need for amplification. These technologies have revolutionized genomics by providing longer read lengths, faster sequencing times, and the ability to detect epigenetic modifications.
History
The development of third-generation sequencing technologies began in the early 2000s as researchers sought to overcome the limitations of second-generation sequencing technologies, such as short read lengths and the need for PCR amplification. The first commercially available third-generation sequencer was released by Pacific Biosciences in 2011.
Technologies
Several third-generation sequencing technologies have been developed, each with unique mechanisms and advantages.
Single-Molecule Real-Time (SMRT) Sequencing
Single-Molecule Real-Time Sequencing is a technology developed by Pacific Biosciences. It uses zero-mode waveguides (ZMWs) to observe the synthesis of DNA in real-time. This method allows for the detection of long reads, often exceeding 10,000 base pairs, and can also identify epigenetic modifications such as DNA methylation.
Nanopore Sequencing
Nanopore sequencing is a technology developed by Oxford Nanopore Technologies. It involves passing a single DNA molecule through a nanopore and measuring changes in electrical current to determine the sequence of bases. This technology is notable for its ability to produce ultra-long reads, sometimes over 100,000 base pairs, and for its portability, as devices like the MinION are small and easy to use in the field.
Applications
Third-generation sequencing has a wide range of applications in various fields of biology and medicine.
Genomics
In genomics, third-generation sequencing is used for whole genome sequencing, particularly for complex genomes with repetitive regions that are difficult to resolve with short-read technologies. It is also used for de novo genome assembly and for sequencing highly heterozygous genomes.
Transcriptomics
In transcriptomics, third-generation sequencing allows for the sequencing of full-length mRNA transcripts, providing a more complete view of the transcriptome. This is particularly useful for identifying alternative splicing events and for characterizing isoforms.
Epigenomics
Third-generation sequencing technologies can directly detect epigenetic modifications such as DNA methylation and histone modifications, providing insights into the regulation of gene expression and the role of epigenetics in disease.
Clinical Applications
In the clinical setting, third-generation sequencing is used for cancer genomics, where it helps identify structural variants and mutations that drive cancer. It is also used in infectious disease diagnostics, allowing for rapid identification of pathogens and their resistance genes.
Advantages and Limitations
Advantages
- Long Read Lengths: Third-generation sequencing provides much longer read lengths compared to second-generation technologies, which is beneficial for resolving complex genomic regions. - Real-Time Sequencing: The ability to sequence in real-time allows for faster data acquisition and analysis. - Direct Detection of Modifications: These technologies can directly detect epigenetic modifications without the need for additional chemical treatments.
Limitations
- Error Rates: Third-generation sequencing technologies generally have higher error rates compared to second-generation sequencing, although this is being improved with advances in technology and bioinformatics. - Cost: The cost per base is higher than that of second-generation sequencing, although this is decreasing over time.
Future Directions
The future of third-generation sequencing is promising, with ongoing developments aimed at improving accuracy, reducing costs, and expanding applications. Integration with other technologies, such as CRISPR-Cas9 for targeted sequencing, is also being explored.
See Also
- Second-generation sequencing - Genome sequencing - Epigenetics
References
External Links
- [Pacific Biosciences](https://www.pacb.com/)
- [Oxford Nanopore Technologies](https://nanoporetech.com/)
| Genomics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Molecular biology | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Third-generation sequencing
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD